FDA’s top drug regulator resigns
Digest more
Sales and production of the sauces made by First and Last Bakery have been suspended to ensure compliance with regulations, ...
The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...
The FDA announced it will relax certain rules for approving low-cost versions of some high-priced medications.
Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower ...
Shares of Biohaven fell more than 40% on Wednesday after the U.S. Food and Drug Administration declined to approve its experimental treatment for a rare brain disorder.
The FDA has approved Kygevvi (doxecitine and doxribtimine) for the treatment of TK2d in adults and pediatric patients with an age of symptom onset on or before 12 years.
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
The U.S. Food and Drug Administration recalled more than 580,000 bottles of a blood pressure medication. Is your medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results